{"author": null, "casenumber": "CA 14/2000", "casename": "Genelabs Diagnostics Pte Ltd v Institut Pasteur and Another", "citation": "[2000] SGCA 60", "coram": "Chao Hick Tin JA; L P Thean JA; Yong Pung How CJ", "counsel": "Tan Tee Jim SC and Jason Chan (Allen & Gledhill) for the appellants; Tony Yeo, Gerald Koh and Celeste Ang (Drew & Napier) for the respondents", "headings": [], "decorations": [], "tags": ["Patents and Inventions", "Patents and Inventions/Novelty", "Equity/Defences/Acquiescence", "Patents and Inventions/Infringement", "Patents and Inventions/Inventive step"], "tags-parsed": ["Patents and Inventions/Novelty/Whether prior art documents should be read collectively or individually/Whether prior art anticipated invention/Whether prior art disclosed existence of HIV-2/ss 13(1), 14(1 & 14(2) Patents Act (Cap 221)", "Patents and Inventions/Inventive step/State of art at priority date from mantle of person skilled in art/Whether trial judge had sufficient regard to state of art/s 15 Patents Act (Cap 221)", "Patents and Inventions/Sufficiency of disclosure/Whether specification enabled invention to be understood and carried into effect by person skilled in art/Whether insufficient disclosure because immuno-reactive portions of amino acid sequence not revealed/s 80(1)(c) Patents Act (Cap 221)", "Patents and Inventions/Infringement/Whether relevant claims of patent infringed -Whether addition of five amino acids in test kit to 18mer a material difference/Whether process used by test kit entailed process which fell within claim of patent", "Equity/Defences/Acquiescence/Whether party stood by as to induce another to commit the act/Whether there was change of position in reliance on acquiescence"]}